| 1 |
32934736 | Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cells. | 2020 Nov |
2 |
| 2 |
31185279 | Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. | 2019 Sep |
1 |
| 3 |
28888979 | Resveratrol, piceatannol and analogs inhibit activation of both wild-type and T877A mutant androgen receptor. | 2017 Nov |
3 |
| 4 |
28903374 | Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells. | 2017 Aug 15 |
2 |
| 5 |
26902145 | BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. | 2016 Feb 23 |
1 |
| 6 |
24726691 | Effects of resveratrol and other wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells. | 2014 Jul-Aug |
4 |
| 7 |
24887556 | Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells. | 2014 |
4 |
| 8 |
25297617 | Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer. | 2014 |
3 |
| 9 |
25414773 | Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells. | 2014 Sep |
4 |
| 10 |
24579014 | Resveratrol in prostate diseases - a short review. | 2013 |
1 |
| 11 |
22700762 | Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells. | 2012 Nov-Dec |
7 |
| 12 |
22788991 | Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models. | 2012 Sep |
1 |
| 13 |
23272133 | Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. | 2012 |
1 |
| 14 |
21073951 | Inhibitory mechanisms of the transcriptional activity of androgen receptor by resveratrol: Implication of DNA binding and acetylation of the receptor. | 2011 Jan |
12 |
| 15 |
21965742 | Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. | 2011 Oct |
5 |
| 16 |
19661309 | Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. | 2009 Aug |
1 |
| 17 |
19816598 | Repressive effects of resveratrol on androgen receptor transcriptional activity. | 2009 Oct 9 |
9 |
| 18 |
18439064 | Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. | 2008 Jan-Mar |
2 |
| 19 |
18202547 | Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. | 2007 Dec |
15 |
| 20 |
15042621 | Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. | 2004 May 1 |
6 |
| 21 |
15327830 | Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells. | 2004 Sep 30 |
2 |
| 22 |
12237244 | Androgen receptors in prostate cancer. | 2002 Sep |
1 |
| 23 |
10769659 | Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. | 2000 Jan-Feb |
2 |
| 24 |
10328958 | Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. | 1999 May 25 |
3 |
| 25 |
10606230 | Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. | 1999 Dec 1 |
1 |